Autologous Platelet-Rich Fibrin in the Treatment of Refractory Macular Holes. (6th November 2019)

• Record Type: Journal Article
• Authors: Koytak, Arif; Nuhoglu, Fadime; Bayraktar, Havvanur; Ercan, Rukiye; Ozdemir, Hakan
• Other Names: Giusti Cristiano Academic Editor.
• Is Part Of: Case reports in ophthalmological medicine. Volume 2019(2019)
• Publication Date: 2019-11-06
• Subjects: Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Ophthalmology; Eye Diseases; Eye -- Diseases; Ophthalmology; Electronic journals; Periodicals; Periodicals; Case Reports; Fulltext; Internet Resources; Periodicals; 617.7
• DOI: 10.1155/2019/6054215
• Languages: English
• ISSNs: 2090-6722

Abstract

Abstract : Purpose. To describe a novel method for the treatment of refractory macular holes. Methods. Two case reports on the use of autologous platelet rich fibrin (PRF), followed by sulfur hexafluoride gas tamponade to facilitate closure of refractory macular holes. Results. Macular holes were succesfully closed within a week in both cases. Best corrected Snellen visual acuities improved from counting fingers to 0.16 in the first case, and from 0.05 to 0.2 in the second case. No complication occurred during or after the procedures. Conclusion. The use of autologous PRF seems to be a safe and effective alternative method for the treatment of refractory macular holes. Further experience and studies are required to assess the value of autologous PRF in the management of challenging macular hole cases of different etiologies. To the best of our knowledge, this is the first use of autologous PRF in the treatment of macular holes.